Capital Research Global Investors Pet Iq, Inc. Transaction History

Capital Research Global Investors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.82 - $12.07 $634,785 - $1.12 Million	-93,077 Reduced 10.57%	787,484 $7.26 Million
Q3 2022 Nov 14, 2022	SELL	$6.9 - $18.16 $1.62 Million - $4.26 Million	-234,539 Reduced 21.03%	880,561 $6.08 Million
Q2 2022 Aug 15, 2022	BUY	$14.09 - $25.12 $898,124 - $1.6 Million	63,742 Added 6.06%	1,115,100 $18.7 Million
Q1 2022 May 16, 2022	BUY	$17.92 - $24.4 $12.6 Million - $17.1 Million	700,358 Added 199.53%	1,051,358 $25.7 Million
Q4 2021 Feb 14, 2022	BUY	$19.97 - $25.91 $3.38 Million - $4.39 Million	169,500 Added 93.39%	351,000 $7.97 Million
Q3 2021 Nov 15, 2021	BUY	$23.99 - $38.59 $4.35 Million - $7 Million	181,500 New	181,500 $4.53 Million
Q4 2017 Feb 14, 2018	SELL	$18.04 - $27.27 $7.22 Million - $10.9 Million	-400,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$21.04 - $27.08 $8.42 Million - $10.8 Million	400,000	400,000 $10.8 Million

189

30M

81K

113K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.